Like several Asian countries, Thailand is experiencing a greying population. While interest in healthy ageing is high, the level of innovation for this category of products remains relatively low.

Like several Asian countries, Thailand is experiencing a greying population. While interest in healthy ageing is high, the level of innovation for this category of products remain relatively low, as such, there are huge opportunities for more industry research and product innovation targeted at Thailand ageing population, says our newly crown NutraChampion, who was awarded the title in this year’s NutraIngredients-Asia Awards.

Sports nutrition research coming out of Malaysia could explore local foods sources, such as palm oil, goat’s milk, and black pepper, said the vice-president of Nutrition Society of Malaysia, who has previously studied biopeptides extracted from locally grown rice on athletes.

India’s national research agency is hoping to study cannabidiol (CBD) and its effects on cancer pain relief, the director of the agency has revealed in our latest NutraChampion podcast.

With consumers increasingly demanding scientifically-validated nutra products and ingredients, one of the key scientists in Australia’s national research agency has revealed the three factors that are crucial for a high-quality trial.

Future infant nutrition research should look into the link between nutrients and gut-brain axis and even its impacts decades later when a child reaches adulthood, instead of merely mimicking human breast milk and focusing on only height and weight gain.

A Thai researcher has invented a personalised probiotics dispenser machine that supplies consumers with probiotics strains that they lack in their gut, using bioinformatics and artificial intelligence (AI).

A Thai researcher has invented a personalised probiotics dispenser machine that supply consumers with probiotics strains that they lack in their gut, using bioinformatics and artificial intelligence (AI).

Beta-glucans have the potential to serve as an adjunctive for a range of chronic, inflammatory diseases, alongside its recently documented benefits for COVID-19 patients, a R&D chief has revealed.

In this podcast, explore the latest COVID-19 and nutra developments from Japan firms Kirin, GN Corporation, and ASX-listed MGC Pharma.